Depreciation, Depletion and Amortization in USD of Scinai Immunotherapeutics Ltd. from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Scinai Immunotherapeutics Ltd. quarterly and annual Depreciation, Depletion and Amortization history and change rate from 2021 to 2023.
  • Scinai Immunotherapeutics Ltd. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2023 was $138,000, a 3% increase year-over-year.
  • Scinai Immunotherapeutics Ltd. annual Depreciation, Depletion and Amortization for 2023 was $514,000, a 8.5% decline from 2022.
  • Scinai Immunotherapeutics Ltd. annual Depreciation, Depletion and Amortization for 2022 was $562,000, a 19% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)

Scinai Immunotherapeutics Ltd. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $138,000 +$4,000 +3% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q1 2022 $134,000 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1

Scinai Immunotherapeutics Ltd. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $514,000 -$48,000 -8.5% 01 Jan 2023 31 Dec 2023 20-F 15 May 2024 2023 FY
2022 $562,000 +$91,000 +19% 01 Jan 2022 31 Dec 2022 20-F 15 May 2024 2023 FY
2021 $471,000 01 Jan 2021 31 Dec 2021 20-F 15 May 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.